Last 12 months
Inside the activity.
13 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 9 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 4 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2019 Filed Nov 18, 2019 11:01 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 29,945 | $2.70 | $80,761.67 |
DisclosureSEC source: 0001214659-19-007241 · marketforms-46144.xml · nonDerivative · entry 11 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,346,888 F6 · price: Per share purchase prices on 11/12/2019 ranged from $2.67 to $2.72 Read SEC document |
| October 31, 2019 Filed Nov 18, 2019 11:01 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 6,072 | $2.71 | $16,449.05 |
DisclosureSEC source: 0001214659-19-007241 · marketforms-46144.xml · nonDerivative · entry 10 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,316,943 F5 · price: Per share purchase prices on 10/31/2019 ranged from $2.65 to $2.71 Read SEC document |
| October 30, 2019 Filed Nov 18, 2019 11:01 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 25,000 | $2.85 | $71,350.00 |
DisclosureSEC source: 0001214659-19-007241 · marketforms-46144.xml · nonDerivative · entry 9 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,310,871 F4 · price: Per share purchase prices on 10/30/2019 ranged from $2.81 to $2.90 Read SEC document |
| October 17, 2019 Filed Nov 18, 2019 11:01 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 3,328 | $3.01 | $10,017.28 |
DisclosureSEC source: 0001214659-19-007241 · marketforms-46144.xml · nonDerivative · entry 8 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,285,871 Read SEC document |
| October 16, 2019 Filed Nov 18, 2019 11:01 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 15,000 | $3.14 | $47,055.00 |
DisclosureSEC source: 0001214659-19-007241 · marketforms-46144.xml · nonDerivative · entry 7 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,282,543 F3 · price: Per share purchase prices on 10/16/2019 ranged from $3.10 to $3.18 Read SEC document |
| October 15, 2019 Filed Nov 18, 2019 11:01 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 6,720 | $3.25 | $21,806.40 |
DisclosureSEC source: 0001214659-19-007241 · marketforms-46144.xml · nonDerivative · entry 6 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,267,543 F2 · price: Per share purchase prices on 10/15/2019 ranged from $3.225 to $3.25 Read SEC document |
| October 14, 2019 Filed Nov 18, 2019 11:01 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $0.001 | 6,700 | $3.25 | $21,775.00 |
DisclosureSEC source: 0001214659-19-007241 · marketforms-46144.xml · nonDerivative · entry 5 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,260,823 Read SEC document |
| October 02, 2019 Filed Nov 18, 2019 11:01 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 5,000 | $3.33 | $16,650.00 |
DisclosureSEC source: 0001214659-19-007241 · marketforms-46144.xml · nonDerivative · entry 4 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,254,123 Read SEC document |
| October 01, 2019 Filed Nov 18, 2019 11:01 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 5,000 | $3.44 | $17,200.00 |
DisclosureSEC source: 0001214659-19-007241 · marketforms-46144.xml · nonDerivative · entry 3 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,249,123 Read SEC document |
| September 30, 2019 Filed Nov 18, 2019 11:01 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 17,940 | $3.70 | $66,360.06 |
DisclosureSEC source: 0001214659-19-007241 · marketforms-46144.xml · nonDerivative · entry 2 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,244,123 F1 · price: Per share purchase prices on 09/30/2019 ranged from $3.389 to $3.72 Read SEC document |
| September 30, 2019 Filed Feb 3, 2020 22:13 UTC |
Rowe Michael MVice President, Commercial
|
PurchaseCommon Stock, par value $.0001 | 100 | $3.84 | $384.00 |
DisclosureSEC source: 0001638599-20-000118 · doc4_6496.xml · nonDerivative · entry 1 Rowe Michael M · CIK 0001744774 · Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 Read SEC document |
| September 27, 2019 Filed Nov 18, 2019 11:01 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 312 | $4.00 | $1,248.00 |
DisclosureSEC source: 0001214659-19-007241 · marketforms-46144.xml · nonDerivative · entry 1 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,226,183 Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:22 UTC |
ESHELMAN FREDRIC NDirector
|
GrantStock Option (right to buy) · Derivative | 9,057 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001638599-19-000798 · doc4_6260.xml · derivative · entry 3 ESHELMAN FREDRIC N · CIK 0001033409 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,057 Underlying: Common Stock · 9,057 shares Expires 2029-08-16 F3 · derivative.exercise_date: The option becomes exercisable on the earlier of August 16, 2020 or the date of the Issuer's 2020 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:22 UTC |
ESHELMAN FREDRIC NDirector
|
GrantCommon Stock, par value $.0001 | 8,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001638599-19-000798 · doc4_6260.xml · nonDerivative · entry 1 ESHELMAN FREDRIC N · CIK 0001033409 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,285,499 F1 · shares: Represents restricted stock units that vest on the earlier of August 16, 2020 or the date of the Issuer's 2020 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:21 UTC |
MARIO ERNESTDirector
|
GrantStock Option (right to buy) · Derivative | 9,057 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001638599-19-000794 · doc4_6256.xml · derivative · entry 2 MARIO ERNEST · CIK 0001180469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,057 Underlying: Common Stock · 9,057 shares Expires 2029-08-16 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of August 16, 2020 or the date of the Issuer's 2020 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:21 UTC |
MARIO ERNESTDirector
|
GrantCommon Stock, par value $.0001 | 8,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001638599-19-000794 · doc4_6256.xml · nonDerivative · entry 1 MARIO ERNEST · CIK 0001180469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,779 F1 · shares: Represents restricted stock units that vest on the earlier of August 16, 2020 or the date of the Issuer's 2020 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:20 UTC |
Clauson LukeVP, R&D and Manufacturing
|
GrantStock Option (right to buy) · Derivative | 42,722 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001638599-19-000790 · doc4_6253.xml · derivative · entry 1 Clauson Luke · CIK 0001736840 · VP, R&D and Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,722 Underlying: Common Stock · 42,722 shares Expires 2029-08-16 F1 · derivative.exercise_date: One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:20 UTC |
Clasby Jennifer GVP, Clinical Operations
|
GrantStock Option (right to buy) · Derivative | 42,722 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001638599-19-000791 · doc4_6254.xml · derivative · entry 2 Clasby Jennifer G · CIK 0001728919 · VP, Clinical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,722 Underlying: Common Stock · 42,722 shares Expires 2029-08-16 F1 · derivative.exercise_date: One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:21 UTC |
LEE KENNETH B JRDirector
|
GrantStock Option (right to buy) · Derivative | 9,057 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001638599-19-000795 · doc4_6257.xml · derivative · entry 2 LEE KENNETH B JR · CIK 0001208570 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,057 Underlying: Common Stock · 9,057 shares Expires 2029-08-16 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of August 16, 2020 or the date of the Issuer's 2020 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:21 UTC |
LEE KENNETH B JRDirector
|
GrantCommon Stock, par value $.0001 | 8,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001638599-19-000795 · doc4_6257.xml · nonDerivative · entry 1 LEE KENNETH B JR · CIK 0001208570 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,071 F1 · shares: Represents restricted stock units that vest on the earlier of August 16, 2020 or the date of the Issuer's 2020 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:20 UTC |
GANDOLFO JOHN PChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 53,402 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001638599-19-000789 · doc4_6252.xml · derivative · entry 2 GANDOLFO JOHN P · CIK 0001200155 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,402 Underlying: Common Stock · 53,402 shares Expires 2029-08-16 F1 · derivative.exercise_date: One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:21 UTC |
SUN ANTHONY YDirector
|
GrantStock Option (right to buy) · Derivative | 9,057 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001638599-19-000796 · doc4_6258.xml · derivative · entry 2 SUN ANTHONY Y · CIK 0001377952 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,057 Underlying: Common Stock · 9,057 shares Expires 2029-08-16 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of August 16, 2020 or the date of the Issuer's 2020 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:21 UTC |
SUN ANTHONY YDirector
|
GrantCommon Stock, par value $.0001 | 8,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001638599-19-000796 · doc4_6258.xml · nonDerivative · entry 1 SUN ANTHONY Y · CIK 0001377952 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,071 F1 · shares: Represents restricted stock units that vest on the earlier of August 16, 2020 or the date of the Issuer's 2020 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:21 UTC |
LaBelle Curt HDirector
|
GrantStock Option (right to buy) · Derivative | 45,256 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001638599-19-000793 · doc4_6267.xml · derivative · entry 4 LaBelle Curt H · CIK 0001396235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,256 Underlying: Common Stock · 45,256 shares Expires 2029-08-16 F2 · derivative.exercise_date: One-third of the option became exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:21 UTC |
MATHER CHARLES E IVDirector
|
GrantStock Option (right to buy) · Derivative | 9,057 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001638599-19-000797 · doc4_6259.xml · derivative · entry 2 MATHER CHARLES E IV · CIK 0001563422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,057 Underlying: Common Stock · 9,057 shares Expires 2029-08-16 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of August 16, 2020 or the date of the Issuer's 2020 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:21 UTC |
MATHER CHARLES E IVDirector
|
GrantCommon Stock, par value $.0001 | 8,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001638599-19-000797 · doc4_6259.xml · nonDerivative · entry 1 MATHER CHARLES E IV · CIK 0001563422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,071 F1 · shares: Represents restricted stock units that vest on the earlier of August 16, 2020 or the date of the Issuer's 2020 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 21:20 UTC |
Rowe Michael MVice President of Marketing
|
GrantStock Option (right to buy) · Derivative | 42,722 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001638599-19-000792 · doc4_6255.xml · derivative · entry 2 Rowe Michael M · CIK 0001744774 · Vice President of Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,722 Underlying: Common Stock · 42,722 shares Expires 2029-08-16 F1 · derivative.exercise_date: One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 21:19 UTC |
Ianchulev TsontchoDirector · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 183,703 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001638599-19-000788 · doc4_6247.xml · derivative · entry 5 Ianchulev Tsontcho · CIK 0001728916 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,703 Underlying: Common Stock · 183,703 shares Expires 2029-08-16 F2 · derivative.exercise_date: One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 17:46 UTC |
MARIO ERNESTDirector
|
PurchaseCommon Stock, par value $.0001 | 35,971 | $2.78 | $99,999.38 |
DisclosureSEC source: 0001638599-19-000655 · doc4_6179.xml · nonDerivative · entry 1 MARIO ERNEST · CIK 0001180469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,741 Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 17:46 UTC |
LaBelle Curt HDirector
|
PurchaseCommon Stock, par value $.0001 | 17,985 | $2.78 | $49,998.30 |
DisclosureSEC source: 0001638599-19-000654 · doc4_6180.xml · nonDerivative · entry 1 LaBelle Curt H · CIK 0001396235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,985 Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 21:46 UTC |
Ianchulev TsontchoDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock, par value $.0001 | 233,813 | $2.78 | $650,000.14 |
DisclosureSEC source: 0001638599-19-000653 · doc4_6181.xml · nonDerivative · entry 1 Ianchulev Tsontcho · CIK 0001728916 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,248 Read SEC document |
| May 14, 2019 Filed May 16, 2019 17:19 UTC |
Yoshida ShuheiDirector · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 33,334 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001638599-19-000525 · doc4_6106.xml · derivative · entry 3 Yoshida Shuhei · CIK 0001728901 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,334 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable as to 2,778 shares on August 7, 2017, and becomes exercisable in equal 2,778 share amounts on each of the 11 one-month anniversaries thereafter. Read SEC document |
| May 14, 2019 Filed May 16, 2019 17:19 UTC |
Yoshida ShuheiDirector · 10% owner
|
Exercise / conversionCommon Stock, par value $.0001 | 33,334 | $1.95 | $65,001.30 |
DisclosureSEC source: 0001638599-19-000525 · doc4_6106.xml · nonDerivative · entry 1 Yoshida Shuhei · CIK 0001728901 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 17:29 UTC |
LaBelle Curt HDirector · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 140,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001638599-19-000021 · doc4_5843.xml · derivative · entry 4 LaBelle Curt H · CIK 0001396235 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Private Medical Equity, Inc. Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2025-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 17:29 UTC |
LaBelle Curt HDirector · 10% owner
|
Exercise / conversionCommon Stock, par value $.0001 | 140,000 | $1.24 | $173,600.00 |
DisclosureSEC source: 0001638599-19-000021 · doc4_5843.xml · nonDerivative · entry 1 LaBelle Curt H · CIK 0001396235 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Private Medical Equity, Inc. Disclosed balance after: 606,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:28 UTC |
Ianchulev TsontchoDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 140,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001638599-19-000020 · doc4_5840.xml · derivative · entry 8 Ianchulev Tsontcho · CIK 0001728916 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Private Medical Equity, Inc. Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2025-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:28 UTC |
Ianchulev TsontchoDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 133,686 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001638599-19-000020 · doc4_5840.xml · derivative · entry 7 Ianchulev Tsontcho · CIK 0001728916 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,370 Underlying: Common Stock · 133,686 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable as to 11,140 shares on August 7, 2017, and becomes exercisable in equal 11,140 share amounts on each of the 35 one-month anniversaries thereafter. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:28 UTC |
Ianchulev TsontchoDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001638599-19-000020 · doc4_5840.xml · derivative · entry 6 Ianchulev Tsontcho · CIK 0001728916 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:28 UTC |
Ianchulev TsontchoDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionCommon Stock, par value $.0001 | 140,000 | $1.24 | $173,600.00 |
DisclosureSEC source: 0001638599-19-000020 · doc4_5840.xml · nonDerivative · entry 3 Ianchulev Tsontcho · CIK 0001728916 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Private Medical Equity, Inc. Disclosed balance after: 606,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:28 UTC |
Ianchulev TsontchoDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionCommon Stock, par value $.0001 | 133,686 | $1.95 | $260,687.70 |
DisclosureSEC source: 0001638599-19-000020 · doc4_5840.xml · nonDerivative · entry 2 Ianchulev Tsontcho · CIK 0001728916 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:28 UTC |
Ianchulev TsontchoDirector · Chief Executive Officer · 10% owner
|
Exercise / conversionCommon Stock, par value $.0001 | 40,000 | $1.24 | $49,600.00 |
DisclosureSEC source: 0001638599-19-000020 · doc4_5840.xml · nonDerivative · entry 1 Ianchulev Tsontcho · CIK 0001728916 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 21:21 UTC |
Rowe Michael MVice President of Marketing
|
PurchaseCommon Stock, par value $.0001 | 600 | $4.27 | $2,562.00 |
DisclosureSEC source: 0001638599-18-001126 · doc4_5702.xml · nonDerivative · entry 2 Rowe Michael M · CIK 0001744774 · Vice President of Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 21:21 UTC |
Rowe Michael MVice President of Marketing
|
PurchaseCommon Stock, par value $.0001 | 200 | $4.09 | $818.00 |
DisclosureSEC source: 0001638599-18-001126 · doc4_5702.xml · nonDerivative · entry 1 Rowe Michael M · CIK 0001744774 · Vice President of Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Read SEC document |
| September 19, 2018 Filed Sep 20, 2018 16:17 UTC |
MATHER CHARLES E IVDirector
|
PurchaseCommon Stock, par value $.0001 | 3,000 | $4.78 | $14,340.00 |
DisclosureSEC source: 0001638599-18-001117 · doc4_5697.xml · nonDerivative · entry 2 MATHER CHARLES E IV · CIK 0001563422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,033 F1 · price: This transaction was executed in multiple trades ranging from $4.75 to $4.7885. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| September 18, 2018 Filed Sep 20, 2018 16:17 UTC |
MATHER CHARLES E IVDirector
|
PurchaseCommon Stock, par value $.0001 | 1,000 | $4.80 | $4,800.00 |
DisclosureSEC source: 0001638599-18-001117 · doc4_5697.xml · nonDerivative · entry 1 MATHER CHARLES E IV · CIK 0001563422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,033 Read SEC document |
| September 10, 2018 Filed Sep 18, 2018 16:45 UTC |
Clasby Jennifer GVP, Clinical Operations
|
Exercise / conversionStock Option (right to buy) · Derivative | 28,965 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001638599-18-001111 · doc4_5694.xml · derivative · entry 2 Clasby Jennifer G · CIK 0001728919 · VP, Clinical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,247 Underlying: Common Stock · 28,965 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable as to 2,228 shares on August 7, 2017, and becomes exercisable in equal 2,228 share amounts on each of the 35 one-month anniversaries thereafter. Read SEC document |
| September 10, 2018 Filed Sep 18, 2018 16:45 UTC |
Clasby Jennifer GVP, Clinical Operations
|
Exercise / conversionCommon Stock | 28,965 | $1.95 | $56,481.75 |
DisclosureSEC source: 0001638599-18-001111 · doc4_5694.xml · nonDerivative · entry 1 Clasby Jennifer G · CIK 0001728919 · VP, Clinical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 18:12 UTC |
ESHELMAN FREDRIC NDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 4,465 | $0.00 Strike: $6.20 | $0.00 |
DisclosureSEC source: 0001638599-18-000819 · doc4_5548.xml · derivative · entry 3 ESHELMAN FREDRIC N · CIK 0001033409 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,655 Underlying: Common Stock · 4,465 shares Expires 2028-07-24 F3 · derivative.exercise_date: The option becomes exercisable on the earlier of July 24, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 18:12 UTC |
ESHELMAN FREDRIC NDirector · 10% owner
|
GrantCommon Stock, par value $.0001 | 4,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001638599-18-000819 · doc4_5548.xml · nonDerivative · entry 1 ESHELMAN FREDRIC N · CIK 0001033409 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,277,461 F1 · shares: Represents restricted stock units that vest on the earlier of July 24, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 18:12 UTC |
MARIO ERNESTDirector
|
GrantStock Option (right to buy) · Derivative | 4,465 | $0.00 Strike: $6.20 | $0.00 |
DisclosureSEC source: 0001638599-18-000822 · doc4_5553.xml · derivative · entry 2 MARIO ERNEST · CIK 0001180469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,465 Underlying: Common Stock · 4,465 shares Expires 2028-07-24 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of July 24, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.